최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국식품위생안전성학회지 = Journal of food hygiene and safety, v.37 no.3, 2022년, pp.198 - 205
김정희 ((주)네추럴웨이 R&D센터) , 김은진 ((주)네추럴웨이 R&D센터) , 강다혜 ((주)네추럴웨이 R&D센터) , 김형빈 ((주)네추럴웨이 R&D센터) , 장재영 (순천향대학교 서울병원 소화기내과) , 엄애선 (한양대학교 생활과학대학 식품영양학과) , 김종욱 ((주)네추럴웨이 R&D센터)
Hepatic diseases are divided into two types: alcoholic and non-alcoholic. Non-alcoholic liver injury finally induces fatty liver and damages liver function. Many studies have demonstrated that Ecklonia stolonifera has antioxidative, anti-inflammatory, and hepatoprotective activities. We conducted a ...
Lee, H.J., White paper on liver diseases in Korea. Korean Association for the Study of the Liver, 21 (2021).
National Institute of Food and Drug Safety Evaluation, Guides for safety and efficacy evaluation of health functional food(May help to liver health), (2020).
Kim, H.K., Suh, C.J., Yoon, H.J., Hwang, Y.H., Lee, K.Y., Park, H.Y., Kim, K.H., Kang, M.H., Association between non-alcoholic fatty liver and metabolic diseases. J. Kor. Endocrine. Soc., 17, 526-534 (2002).
Eslam, M., Sanyal, A.J., George, J., Sanyal, A., Neuschwander-Tetri, B., Tiribelli, C., Kleiner, D.E., Brunt, E., Bugianesi, E., Yki-Jarvinen, H., MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology, 158, 1999-2014 (2020).
Friedman, S.L., Neuschwander-Tetri, B.A., Rinella, M., Sanyal, A.J., Mechanisms of NAFLD development and therapeutic strategies. Nat. Med., 24, 908-922 (2018).
Lee, H.J., Non-alcoholic fatty liver disease clinical practice guidelines. Korean Association for the Study of the Liver, 5-14 (2021).
Liss, K.H., Finck, B.N., PPARs and nonalcoholic fatty liver disease. Biochimie, 136, 65-74 (2017).
Lee, H.J., Non-alcoholic fatty liver disease clinical practice guidelines. Korean Association for the Study of the Liver, 40-45 (2021).
Ministry of Food and Drug Safety, 2022.02.11., Available from: https://www.foodsafetykorea.go.kr/main.do
Choi, J.S., Han, Y.R., Byeon, J.S., Choung, S.Y., Sohn, H.S., Jung, H.A., Protective effect of fucosterol isolated from the edible brown algae, Ecklonia stolonifera and Eisenia bicyclis, on tert-butyl hydroperoxide- and tacrine-induced HepG2 cell injury. J. Pharm. Pharmacol., 67, 1170-1178 (2015).
Lee, M.S., Kim, J.I., Utsuki, T., Park, N.G., Kim, H.R., Cytoprotective effects of phlorofucofuroeckol A isolated from Ecklonia stolonifera against tacrine-treated HepG2 cells. Fitoterapia, 83, 1060-1067 (2012).
Lee, M.S., Shin, T., Utsuki, T., Choi, J.S., Byun, D.S., Kim, H.R., Isolation and identification of phlorotannins from Ecklonia stolonifera with antioxidant and hepatoprotective properties in tacrine-treated HepG2 cells. J. Agric. Food Chem., 60, 5340-5349 (2012).
Yoon, J.S., Kasin Yadunandam, A., Kim, S.J., Woo, H.C., Kim, H.R., Kim, G.D., Dieckol, isolated from Ecklonia stolonifera, induces apoptosis in human hepatocellular carcinoma Hep3B cells. J. Nat. Med., 67, 519-527 (2013).
Browning, J.D., Horton, J.D., Molecular mediators of hepatic steatosis and liver injury. J. Clin. invest., 114, 147-152 (2004).
Wang, N., Kong, R., Luo, H., Xu, X., Lu, J., Peroxisome proliferator-activated receptors associated with nonalcoholic fatty liver disease. PPAR Res., 6561701 (2017).
Horton, J.D., Goldstein, J.L., Brown, M.S., SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. invest., 109, 1125-1131 (2002).
You, M., Crabb, D.W., Recent advances in alcoholic liver disease II. minireview: molecular mechanisms of alcoholic fatty liver. Am. J. Physiol. Gastrointest. Liver Physiol., 287, G1-G6 (2004).
Katagiri, T., Sunagawa, Y., Maekawa, T., Funamoto, M., Shimizu, S., Shimizu, K., Katanasaka, Y., Komiyama, M., Hawke, P., Hara, H., Mori, K., Hasegawa, K., Morimoto, T., Ecklonia stolonifera Okamura extract suppresses myocardial infarction-induced left ventricular systolic dysfunction by inhibiting p300-HAT activity. Nutrients, 14, 580 (2022).
Jin, H., Lee, K., Chei, S., Oh, H.J., Lee, K.P., Lee, B.Y., Ecklonia stolonifera extract suppresses lipid accumulation by promoting lipolysis and adipose browning in high-fat diet-induced obese male mice. Cells, 9, 871 (2020).
Han, B., Kim, S.M., Nam, G.E., Kim, S.H., Park, S.J., Park, Y.K., Baik, H.W., A randomized, double-Blind, placebo-controlled, multi-centered clinical study to evaluate the efficacy and safety of Artemisia annua L. extract for improvement of liver function. Clin. Nutr. Res., 9, 258 (2020).
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.